{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:54:10Z","timestamp":1768740850820,"version":"3.49.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T00:00:00Z","timestamp":1696723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-SY2021QN-0172"],"award-info":[{"award-number":["Y-SY2021QN-0172"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["2021-MS-190"],"award-info":[{"award-number":["2021-MS-190"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genomics"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ygeno.2023.110725","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T11:29:17Z","timestamp":1697196557000},"page":"110725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dynamic alterations of the transcriptome-wide m6A methylome in cytogenetically normal acute myeloid leukaemia during initial diagnosis and relapse"],"prefix":"10.1016","volume":"115","author":[{"given":"Jinjing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.ygeno.2023.110725_bb0005","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ygeno.2023.110725_bb0010","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","article-title":"Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel","volume":"129","author":"Dohner","year":"2017","journal-title":"Blood."},{"issue":"7728","key":"10.1016\/j.ygeno.2023.110725_bb0015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature."},{"issue":"7","key":"10.1016\/j.ygeno.2023.110725_bb0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ygeno.2023.110725_bb0025","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMoa1614359","article-title":"Midostaurin plus chemotherapy for acute myeloid leukemia with a FLT3 mutation","volume":"377","author":"Stone","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"25","key":"10.1016\/j.ygeno.2023.110725_bb0030","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa1716984","article-title":"Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML","volume":"378","author":"DiNardo","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygeno.2023.110725_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.639387","article-title":"IDH1\/IDH2 inhibition in acute myeloid leukemia","volume":"11","author":"Cerchione","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.ygeno.2023.110725_bb0040","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1038\/s41375-021-01218-0","article-title":"Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies","volume":"35","author":"Stomper","year":"2021","journal-title":"Leukemia."},{"issue":"4","key":"10.1016\/j.ygeno.2023.110725_bb0045","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41375-018-0293-8","article-title":"Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation","volume":"33","author":"Blagitko-Dorfs","year":"2019","journal-title":"Leukemia."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/2159-8290.CD-18-0959","article-title":"The biology of m(6)A RNA methylation in normal and malignant hematopoiesis","volume":"9","author":"Vu","year":"2019","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.ygeno.2023.110725_bb0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s40778-020-00178-y","article-title":"The role of RNA epigenetic modification in normal and malignant hematopoiesis","volume":"6","author":"Vasic","year":"2020","journal-title":"Curr. Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0060","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-019-1109-9","article-title":"Functions of N6-methyladenosine and its role in cancer","volume":"18","author":"He","year":"2019","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.ygeno.2023.110725_bb0065","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res."},{"issue":"10","key":"10.1016\/j.ygeno.2023.110725_bb0070","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2217\/epi-2020-0372","article-title":"Transcriptome-wide N6-methyladenosine methylation landscape of coronary artery disease","volume":"13","author":"Deng","year":"2021","journal-title":"Epigenomics."},{"issue":"3","key":"10.1016\/j.ygeno.2023.110725_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/ph14030218","article-title":"m6A RNA methylation in systemic autoimmune diseases-a new target for epigenetic-based therapy?","volume":"14","author":"Wardowska","year":"2021","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"9","key":"10.1016\/j.ygeno.2023.110725_bb0080","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/15592294.2020.1834917","article-title":"Comprehensive analysis of transcriptome-wide m(6)A methylome in the anterior capsule of the lens of high myopia patients","volume":"16","author":"Wen","year":"2021","journal-title":"Epigenetics."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0085","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-020-01216-3","article-title":"Mechanism of RNA modification N6-methyladenosine in human cancer","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.ygeno.2023.110725_bb0090","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat. Med."},{"issue":"7683","key":"10.1016\/j.ygeno.2023.110725_bb0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.ygeno.2023.110725_bb0100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.ygeno.2023.110725_bb0105","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41419-018-0843-z","article-title":"METTL3 regulates WTAP protein homeostasis","volume":"9","author":"Sorci","year":"2018","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.stem.2019.03.021","article-title":"Targeting the RNA m(6)A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia","volume":"25","author":"Paris","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.stem.2020.04.009","article-title":"RNA demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia","volume":"27","author":"Shen","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.stem.2020.04.001","article-title":"Leukemogenic chromatin alterations promote AML leukemia stem cells via a KDM4C-ALKBH5-AXL signaling axis","volume":"27","author":"Wang","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.ygeno.2023.110725_bb0130","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/leu.2014.16","article-title":"WTAP is a novel oncogenic protein in acute myeloid leukemia","volume":"28","author":"Bansal","year":"2014","journal-title":"Leukemia."},{"issue":"6","key":"10.1016\/j.ygeno.2023.110725_bb0135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/0008-5472.CAN-21-4249","article-title":"The RNA m6A reader YTHDF1 is required for acute myeloid leukemia progression","volume":"83","author":"Hong","year":"2023","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.ygeno.2023.110725_bb0140","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","article-title":"The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia","volume":"40","author":"Weng","year":"2022","journal-title":"Cancer Cell"},{"issue":"7671","key":"10.1016\/j.ygeno.2023.110725_bb0145","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature23883","article-title":"m(6)A modulates haematopoietic stem and progenitor cell specification","volume":"549","author":"Zhang","year":"2017","journal-title":"Nature."},{"issue":"46","key":"10.1016\/j.ygeno.2023.110725_bb0150","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1021\/acs.biochem.1c00254","article-title":"The m(6)A consensus motif provides a paradigm of epitranscriptomic studies","volume":"60","author":"Wang","year":"2021","journal-title":"Biochemistry."},{"issue":"5","key":"10.1016\/j.ygeno.2023.110725_bb0155","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1182\/bloodadvances.2020003727","article-title":"Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia","volume":"5","author":"Walker","year":"2021","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0160","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12935-021-01839-6","article-title":"Comprehensive analysis of the transcriptome-wide m(6)A methylome in invasive malignant pleomorphic adenoma","volume":"21","author":"Han","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.ygeno.2023.110725_bb0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/15592294.2020.1805684","article-title":"Comprehensive analysis of the transcriptome-wide m6A methylome in colorectal cancer by MeRIP sequencing","volume":"16","author":"Zhang","year":"2021","journal-title":"Epigenetics."},{"key":"10.1016\/j.ygeno.2023.110725_bb0170","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1186\/s12935-020-01554-8","article-title":"Joint analysis of lncRNA m(6)A methylome and lncRNA\/mRNA expression profiles in gastric cancer","volume":"20","author":"Lv","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.ygeno.2023.110725_bb0175","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41375-021-01225-1","article-title":"RNA methylation in hematological malignancies and its interactions with other epigenetic modifications","volume":"35","author":"Yao","year":"2021","journal-title":"Leukemia."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00432-020-03373-w","article-title":"High Wilms\u2019 tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m(6)A methylation of MYC mRNA","volume":"147","author":"Naren","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.ygeno.2023.110725_bb0185","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1038\/s41388-021-01818-1","article-title":"YTHDF2 is a potential target of AML1\/ETO-HIF1\u03b1 loop-mediated cell proliferation in t(8;21) AML","volume":"40","author":"Chen","year":"2021","journal-title":"Oncogene."},{"issue":"9","key":"10.1016\/j.ygeno.2023.110725_bb0190","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1021\/acs.molpharmaceut.8b00522","article-title":"Identification of natural compound radicicol as a potent FTO inhibitor","volume":"15","author":"Wang","year":"2018","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.ygeno.2023.110725_bb0195","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.ygeno.2023.110725_bb0205","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.7150\/thno.55574","article-title":"Saikosaponin D exhibits anti-leukemic activity by targeting FTO\/m(6)A signaling","volume":"11","author":"Sun","year":"2021","journal-title":"Theranostics."},{"issue":"5","key":"10.1016\/j.ygeno.2023.110725_bb0210","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","article-title":"R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m(6)A\/PFKP\/LDHB axis","volume":"81","author":"Qing","year":"2021","journal-title":"Mol. Cell"},{"issue":"20","key":"10.1016\/j.ygeno.2023.110725_bb0215","doi-asserted-by":"crossref","first-page":"13310","DOI":"10.1021\/acsomega.1c01289","article-title":"Rational design of novel anticancer small-molecule RNA m6A demethylase ALKBH5 inhibitors","volume":"6","author":"Selberg","year":"2021","journal-title":"ACS Omega"},{"issue":"7860","key":"10.1016\/j.ygeno.2023.110725_bb0220","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","article-title":"Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia","volume":"593","author":"Yankova","year":"2021","journal-title":"Nature."},{"issue":"9","key":"10.1016\/j.ygeno.2023.110725_bb0225","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.3390\/ijms22094314","article-title":"Divergence of intracellular trafficking of sphingosine kinase 1 and sphingosine-1-phosphate receptor 3 in MCF-7 breast cancer cells and MCF-7-derived stem cell-enriched mammospheres","volume":"22","author":"Sukocheva","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ygeno.2023.110725_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109850","article-title":"Dysregulation of lysophospholipid signaling by p53 in malignant cells and the tumor microenvironment","volume":"78","author":"Lee","year":"2021","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.ygeno.2023.110725_bb0235","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3390\/cancers13081898","article-title":"Targeting the sphingosine kinase\/sphingosine-1-phosphate signaling axis in drug discovery for cancer therapy","volume":"13","author":"Gupta","year":"2021","journal-title":"Cancers."},{"issue":"8","key":"10.1016\/j.ygeno.2023.110725_bb0240","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/cas.12459","article-title":"Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia","volume":"105","author":"Han","year":"2014","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.ygeno.2023.110725_bb0245","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00262-011-1118-z","article-title":"Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation?","volume":"60","author":"Ersv\u00e6r","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1084\/jem.20151414","article-title":"Niche WNT5A regulates the actin cytoskeleton during regeneration of hematopoietic stem cells","volume":"214","author":"Schreck","year":"2017","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.ygeno.2023.110725_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081882","article-title":"Cytoskeletal dynamics in epithelial-mesenchymal transition: insights into therapeutic targets for cancer metastasis","volume":"13","author":"Datta","year":"2021","journal-title":"Cancers."},{"key":"10.1016\/j.ygeno.2023.110725_bb0260","article-title":"MLK3 is associated with poor prognosis in patients with glioblastomas and actin cytoskeleton remodeling in glioblastoma cells","volume":"10","author":"Zhu","year":"2020","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0265","doi-asserted-by":"crossref","DOI":"10.1097\/CAD.0000000000001188","article-title":"LINC00987 knockdown inhibits the progression of acute myeloid leukemia by suppressing IGF2BP2-mediated PA2G4 expression","volume":"33","author":"Liu","year":"2022","journal-title":"Anti-Cancer Drugs"},{"issue":"7\u20138","key":"10.1016\/j.ygeno.2023.110725_bb0270","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10495-023-01846-0","article-title":"IGF2BP2 promotes lncRNA DANCR stability mediated glycolysis and affects the progression of FLT3-ITD+acute myeloid leukemia","volume":"28","author":"Wu","year":"2023","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13045-020-01021-x","article-title":"HOMER3 facilitates growth factor-mediated \u03b2-catenin tyrosine phosphorylation and activation to promote metastasis in triple negative breast cancer","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"20","key":"10.1016\/j.ygeno.2023.110725_bb0280","first-page":"6853","article-title":"Increased HSPG2 expression independently predicts poor survival in patients with oligoastrocytoma and oligodendroglioma","volume":"22","author":"Ma","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0285","doi-asserted-by":"crossref","first-page":"12492","DOI":"10.1038\/s41598-019-48993-6","article-title":"Discovery of HSPG2 (Perlecan) as a therapeutic target in triple negative breast cancer","volume":"9","author":"Kalscheuer","year":"2019","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ygeno.2023.110725_bb0290","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/s41390-020-01199-3","article-title":"Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach","volume":"89","author":"Depreter","year":"2021","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.ygeno.2023.110725_bb0295","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/gcc.20500","article-title":"Identification of genes with abnormal expression changes in acute myeloid leukemia","volume":"47","author":"Stirewalt","year":"2008","journal-title":"Genes Chromosom. Cancer"},{"issue":"4","key":"10.1016\/j.ygeno.2023.110725_bb0300","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.7314\/APJCP.2013.14.4.2525","article-title":"Growth and differentiation effects of Homer3 on a leukemia cell line","volume":"14","author":"Li","year":"2013","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"6","key":"10.1016\/j.ygeno.2023.110725_bb0305","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41419-020-2694-7","article-title":"HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia","volume":"11","author":"Zhou","year":"2020","journal-title":"Cell Death Dis."}],"container-title":["Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754323001696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0888754323001696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:42:07Z","timestamp":1760164927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0888754323001696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0888754323001696"],"URL":"https:\/\/doi.org\/10.1016\/j.ygeno.2023.110725","relation":{},"ISSN":["0888-7543"],"issn-type":[{"value":"0888-7543","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic alterations of the transcriptome-wide m6A methylome in cytogenetically normal acute myeloid leukaemia during initial diagnosis and relapse","name":"articletitle","label":"Article Title"},{"value":"Genomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygeno.2023.110725","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110725"}}